A01K 2217/05
Animals comprising random inserted nucleic acids
Official title: Animals comprising random inserted nucleic acids (transgenic)
A01K2217/05 (Animals comprising random inserted nucleic acids) appears on 4,879 US grants and 6,457 published applications in this corpus.
Search patents in A01K- Granted patents
- 4,879
- Published applications
- 6,457
- Assignees
- 2,053
- Inventors
- 10,267
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 0 | 0 |
| 1991 | 2 | 0 |
| 1992 | 9 | 0 |
| 1993 | 9 | 0 |
| 1994 | 12 | 0 |
| 1995 | 18 | 0 |
| 1996 | 72 | 0 |
| 1997 | 121 | 0 |
| 1998 | 241 | 0 |
| 1999 | 258 | 0 |
| 2000 | 262 | 0 |
| 2001 | 273 | 56 |
| 2002 | 285 | 666 |
| 2003 | 274 | 850 |
| 2004 | 262 | 709 |
| 2005 | 199 | 575 |
| 2006 | 299 | 425 |
| 2007 | 262 | 359 |
| 2008 | 222 | 309 |
| 2009 | 220 | 316 |
| 2010 | 219 | 277 |
| 2011 | 174 | 215 |
| 2012 | 162 | 172 |
| 2013 | 136 | 164 |
| 2014 | 96 | 149 |
| 2015 | 112 | 110 |
| 2016 | 91 | 161 |
| 2017 | 87 | 128 |
| 2018 | 84 | 127 |
| 2019 | 74 | 117 |
| 2020 | 67 | 107 |
| 2021 | 49 | 88 |
| 2022 | 53 | 94 |
| 2023 | 46 | 68 |
| 2024 | 42 | 94 |
| 2025 | 45 | 75 |
| 2026 | 37 | 46 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Genetically modified non-human animal with human or chimeric TFR122 Sep 2026US 12,740,550 B2Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
- Methods of treating rheumatoid arthritis using RNA-guided genome editing of HLA gene22 Sep 2026US 12,742,179 B2National Jewish Health
- Non-viral transgenesis15 Sep 2026US 12,735,719 B2The Regents of the University of California
- Methods of treating mitochondrial disorders1 Sep 2026US 12,723,062 B2The Regents of the University of California
- Multi-transgenic pig for Xenotransplantation25 Aug 2026US 12,714,077 B2Revivicor, Inc.
- Humanized ace2-expressing transgenic mouse susceptible to sars-cov-2 virus infection and method for producing same8 Oct 2026US 2026/0305587 A1Seoul National University R&Db Foundation
- Mouse model with humanized telomere1 Oct 2026US 2026/0293864 A1Washington State Univesity
- Single-sex chicken with toxin-antitoxin system1 Oct 2026US 2026/0293865 A1New York University
- Use of inhibitors of adam12 as adjuvants in tumor therapies24 Sep 2026US 2026/0286009 A1Institut National de la Sante et de la Recherche Medicale
- Compositions and methods for determining genetic polymorphisms in the tmem216 gene24 Sep 2026US 2026/0286437 A1The Regents of the University of California
Most cited
By later US patents
- Ransgenic non-human animals for producing heterologous antibodies1,941US 5,545,806 AGenPharm International, Inc. · 1996
- Transgenic non-human animals capable of producing heterologous antibodies of various isotypes1,748US 5,569,825 AGenPharm International, Inc. · 1996
- Transgenic non-human animals capable of producing heterologous antibodies1,680US 5,633,425 AGenPharm International, Inc. · 1997
- Transgenic non-human animals for producing heterologous antibodies1,604US 5,625,126 AGenPharm International, Inc. · 1997
- Production of antibodies from transgenic animals1,567US 5,545,807 AMedical Research Council · 1996